Hyperion Biosystems has created a suite of diagnostic devices that leverage our expertise in computer vision and physics-based algorithms to deliver exquisite performance at the lowest price.

Designing Diagnostics for the Future

What We Offer

We work with leaders in the point-of-care and at-home testing markets to exponentially improve the sensitivity and specificity of their diagnostic offerings without diverting or disrupting resources.

HALO

®

Identifying false positives, delineating non-specific binding and mitigating assay defects enables higher assay performance without redesign.

Learn More →

HELIOS

TM

Extraordinary new method for multiplex detection of circulating tumor and cell-free DNA.

Coming Soon →

Client Success

"Companies prosper when the cleverness of innovation meets the timely needs of the customer.”

Eric Whitters

COO, Hycor Biomedical, LLC.

14 Examples of custom solutions delivered in a week or less

10x

Average sensitivity enhancement

10,000

Assays run with our algorithms

Featured Stories

Hyperion Biosystems and Colorcon Enter into Licensing Agreement

May 13, 2025

Hyperion Biosystems and Colorcon today announced a licensing agreement to commercialize and market a jointly-developed, anti-counterfeiting technology for solid oral dosage pharmaceutical and nutraceutical products.

Learn More →